Question 1

What is Monte Rosa Therapeutics, Inc.'s total current liabilities?

Accepted Answer

Monte Rosa Therapeutics, Inc. (GLUE) reported total current liabilities of $59.66M in Q2 2026.

Question 2

How has Monte Rosa Therapeutics, Inc.'s total current liabilities changed year-over-year?

Accepted Answer

Monte Rosa Therapeutics, Inc.'s total current liabilities increased by 42.5% year-over-year, from $41.85M to $59.66M.

Question 3

What is the long-term trend for Monte Rosa Therapeutics, Inc.'s total current liabilities?

Accepted Answer

Over 5 years (2020 to 2025), Monte Rosa Therapeutics, Inc.'s total current liabilities has grown at a 17.0% compound annual growth rate (CAGR), from $29.28M to $64.21M.

Question 4

What does total current liabilities mean?

Accepted Answer

The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

(in thousands, except share and per share amounts)	June 30, 2026	December 31, 2025
Accrued expenses and other current liabilities	25,773	26,694
Current deferred revenue	22,103	29,571
Current portion of operating lease liability	4,630	4,397
Total current liabilities	59,658	64,212
Deferred revenue, net of current	105,623	111,332
Defined benefit plan liability	5,242	5,265
Operating lease liability, net of current	33,357	34,794
Total liabilities	203,880	215,603

Total Current Liabilities at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Monte Rosa Therapeutics, Inc.'s total current liabilities.

Monte Rosa Therapeutics, Inc. GLUE Total Current Liabilities